DataKnowledgeCloudtrainingcoordination

COL P40199-1 GLY 000038 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)

Protein:

CEAM6 HUMAN

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Collection:

human proteoform glycosylation sites uniprotkb.csv

File (Entity type)

Description:Information for protein P40199-1 in the context of file GLY_000038

Creation Time:2026-03-02 19:56:32.000000

Results found

Linked to

	Label	Description
	p40199-1 224asn 224asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	CEAM6 HUMAN Protein (Entity type)	Carcinoembryonic antigen-related cell adhesion molecule 6 (precursor)
	p40199-1 256asn 256asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p40199-1 197asn 197asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p40199-1 152asn 152asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p40199-1 115asn 115asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p40199-1 111asn 111asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p40199-1 288asn 288asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p40199-1 173asn 173asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	p40199-1 309asn 309asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification

Post Translational Modification

p40199-1 224asn 224asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Protein

CEAM6 HUMAN

Protein (Entity type)

Carcinoembryonic antigen-related cell adhesion molecule 6 (precursor)

Post Translational Modification

p40199-1 256asn 256asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p40199-1 197asn 197asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p40199-1 152asn 152asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p40199-1 115asn 115asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p40199-1 111asn 111asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p40199-1 288asn 288asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p40199-1 173asn 173asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p40199-1 309asn 309asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.